Quarterly Call Option Transactions in Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR) during . The information is specifically focused on institutions that hold call options of ARROWHEAD PHARMACEUTICALS, INC..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 26,700 | 13,541 | 40,241 | 238,400 | 2,200 | 240,600 | -200,359 | |
| Q4 2021 | 46,000 | 81,400 | 127,400 | 39,200 | 0 | 39,200 | 88,200 | |
| Q1 2022 | 48,800 | 1,000,000 | 1,048,800 | 426,800 | 33,700 | 460,500 | 588,300 | |
| Q2 2022 | 52,400 | 81,400 | 133,800 | 6,500 | 0 | 6,500 | 127,300 | |
| Q3 2022 | 31,900 | 50,000 | 81,900 | 5,900 | 0 | 5,900 | 76,000 | |
| Q4 2022 | 58,100 | 14,500 | 72,600 | 39,400 | 0 | 39,400 | 33,200 | |
| Q1 2023 | 35,600 | 30,000 | 65,600 | 144,100 | 0 | 144,100 | -78,500 | |
| Q2 2023 | 69,300 | 0 | 69,300 | 43,900 | 0 | 43,900 | 25,400 | |
| Q3 2023 | 19,000 | 0 | 19,000 | 62,500 | 0 | 62,500 | -43,500 | |
| Q4 2023 | 153,400 | 260,300 | 413,700 | — | 413,700 | |||
| Q1 2024 | 430,100 | 28,000 | 458,100 | 147,100 | 0 | 147,100 | 311,000 | |
| Q2 2024 | 486,600 | 25,900 | 512,500 | 8,500 | 0 | 8,500 | 504,000 | |
| Q3 2024 | 13,700 | 35,100 | 48,800 | 167,800 | 0 | 167,800 | -119,000 | |